Inhibition of Neutrophils by Hypertonic Saline Involves Pannexin-1, CD39, CD73, and Other Ectonucleotidases

被引:18
|
作者
Chen, Yu [1 ]
Bao, Yi [1 ]
Zhang, Jingping [1 ]
Woehrle, Tobias [1 ]
Sumi, Yuka [1 ]
Ledderose, Stephan [1 ]
Li, Xiaoou [1 ]
Ledderose, Carola [1 ]
Junger, Wolfgang G. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA
[2] Ludwig Boltzmann Inst Traumatol, Vienna, Austria
来源
SHOCK | 2015年 / 44卷 / 03期
关键词
TRAUMATIC BRAIN-INJURY; PROTEIN-KINASE P38; HEMORRHAGIC-SHOCK; ATP RELEASE; OXIDATIVE BURST; CELL-ACTIVATION; RESUSCITATION; RECEPTORS; HEMICHANNELS; HYPOTENSION;
D O I
10.1097/SHK.0000000000000402
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Hypertonic saline (HS) resuscitation has been studied as a possible strategy to reduce polymorphonuclear neutrophil (PMN) activation and tissue damage in trauma patients. Hypertonic saline blocks PMNs by adenosine triphosphate (ATP) release and stimulation of A2a adenosine receptors. Here, we studied the underlying mechanisms in search of possible reasons for the inconsistent results of recent clinical trials with HS resuscitation. Purified human PMNs or PMNs in whole blood were treated with HS to simulate hypertonicity levels found after HS resuscitation (40 mmol/L beyond isotonic levels). Adenosine triphosphate release was measured with a luciferase assay. Polymorphonuclear neutrophil activation was assessed by measuring oxidative burst. The pannexin-1 (panx1) inhibitor (10)panx1 and the gap junction inhibitor carbenoxolone (CBX) blocked ATP release from PMNs in purified and whole blood preparations, indicating that HS releases ATP via panx1 and gap junction channels. Hypertonic saline blocked N-formyl-Met-Leu-Phe-induced PMN activation by 40% in purified PMN preparations and by 60% in whole blood. These inhibitory effects were abolished by (10)panx1 but only partially reduced by CBX, which indicates that panx1 has a central role in the immunomodulatory effects of HS. Inhibition of the ectonucleotidases CD39 and CD73 abolished the suppressive effect of HS on purified PMN cultures but only partially reduced the effect of HS in whole blood. These findings suggest redundant mechanisms in whole blood that may strengthen the immunomodulatory effect of HS in vivo. We conclude that HS resuscitation exerts anti-inflammatory effects that involve panx1, CD39, CD73, and other ectonucleotidases, which produce the adenosine that blocks PMNs by stimulating their A2a receptors. Our findings shed new light on the immunomodulatory mechanisms of HS and suggest possible new strategies to improve the clinical efficacy of hypertonic resuscitation.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 12 条
  • [1] The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
    Allard, Bertrand
    Longhi, Maria Serena
    Robson, Simon C.
    Stagg, John
    IMMUNOLOGICAL REVIEWS, 2017, 276 (01) : 121 - 144
  • [2] High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73
    Kumar, Meera
    Lowery, Robert
    Kumar, Vaishnav
    SLAS DISCOVERY, 2020, 25 (03) : 320 - 326
  • [3] Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways
    Morianos, Ioannis
    Trochoutsou, Aikaterini I.
    Papadopoulou, Gina
    Semitekolou, Maria
    Banos, Aggelos
    Konstantopoulos, Dimitris
    Manousopoulou, Antigoni
    Kapasa, Maria
    Wei, Ping
    Lomenick, Brett
    Belaidi, Elise
    Kalamatas, Themis
    Karageorgiou, Klinta
    Doskas, Triantafyllos
    Sallusto, Federica
    Pan, Fan
    Garbis, Spiros D.
    Quintana, Francisco J.
    Xanthou, Georgina
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (22) : 12269 - 12280
  • [4] A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
    Horenstein, Alberto L.
    Chillemi, Antonella
    Zaccarello, Gianluca
    Bruzzone, Santina
    Quarona, Valeria
    Zito, Andrea
    Serra, Sara
    Malavasi, Fabio
    ONCOIMMUNOLOGY, 2013, 2 (09):
  • [5] Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
    Clayton, Aled
    Al-Taei, Saly
    Webber, Jason
    Mason, Malcolm D.
    Tabi, Zsuzsanna
    JOURNAL OF IMMUNOLOGY, 2011, 187 (02) : 676 - 683
  • [6] Resident Cardiac Immune Cells and Expression of the Ectonucleotidase Enzymes CD39 and CD73 after Ischemic Injury
    Boenner, Florian
    Borg, Nadine
    Burghoff, Sandra
    Schrader, Juergen
    PLOS ONE, 2012, 7 (04):
  • [7] Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
    Perrot, Ivan
    Michaud, Henri-Alexandre
    Giraudon-Paoli, Marc
    Augier, Severine
    Docquier, Aurelie
    Gros, Laurent
    Courtois, Rachel
    Dejou, Cecile
    Jecko, Diana
    Becquart, Ondine
    Rispaud-Blanc, Helene
    Gauthier, Laurent
    Rossi, Benjamin
    Chanteux, Stephanie
    Gourdin, Nicolas
    Amigues, Beatrice
    Roussel, Alain
    Bensussan, Armand
    Eliaou, Jean-Francois
    Bastid, Jeremy
    Romagne, Francois
    Morel, Yannis
    Narni-Mancinelli, Emilie
    Vivier, Eric
    Paturel, Carine
    Bonnefoy, Nathalie
    CELL REPORTS, 2019, 27 (08): : 2411 - +
  • [8] Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
    Horenstein, Alberto L.
    Chillemi, Antonella
    Zini, Roberta
    Quarona, Valeria
    Bianchi, Nicoletta
    Manfredini, Rossella
    Gambari, Roberto
    Malavasi, Fabio
    Ferrari, Davide
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [9] Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression
    Munoz-Godinez, Ricardo
    de Lourdes Mora-Garcia, Maria
    Weiss-Steider, Benny
    Montesinos-Montesinos, Juan Jose
    del Carmen Aguilar-Lemarroy, Adriana
    Garcia-Rocha, Rosario
    Hernandez-Montes, Jorge
    Azucena Don-Lopez, Christian
    Avila-Ibarra, Luis Roberto
    Torres-Pineda, Daniela Berenice
    Molina-Castillo, Gabriela
    Chacon-Salinas, Rommel
    Vallejo-Castillo, Luis
    Perez-Tapia, Sonia Mayra
    Monroy-Garcia, Alberto
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [10] Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways
    Giatromanolaki, Alexandra
    Kouroupi, Maria
    Pouliliou, Stamatia
    Mitrakas, Achilleas
    Hasan, Fatma
    Pappa, Aglaia
    Koukourakis, Michael, I
    LIFE SCIENCES, 2020, 259